OSYPKA AG

OSYPKA AG is a globally renowned company for its innovation and precision in the development and manufacturing of medical devices and accessories in the fields of cardiology and cardiac surgery. Since 1977, the company has been producing electrodes, implantable stimulation electrodes, temporary pacemakers, and post-operative epicardial wires.

OSYPKA AG is recognized for its pioneering work in various medical areas, many of which have become standard practices in the industry. Notably, the company has developed fracture-resistant implantable electrodes and the world's first high-frequency ablation generator for treating cardiac arrhythmias.

Today, OSYPKA's brand products encompass a wide spectrum in cardiac stimulation, cardiac surgery, electrophysiology, as well as interventional and pediatric cardiology. Additionally, OSYPKA AG serves as an experienced and reliable partner for numerous international medical technology companies, offering contract manufacturing and development of components and finished parts.

In addition to its headquarters in Germany, OSYPKA AG has additional locations in the USA and the Czech Republic. The company, primarily owned by the nonprofit Peter Osypka Foundation, is committed to supporting medical research and charitable projects in developing countries.

OSYPKA AG operates in the Health Care, Manufacturing, and Medical Devices industries. Although specific details regarding the last investment and investors are not available, the company's longstanding presence and contributions to the medical technology sector position it as a compelling potential investment opportunity for venture capitalists interested in the healthcare and medical devices markets.